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Small GTPase Rab6 regulates vesicle trafficking at
the level of Golgi via recruitment of numerous and
unrelated effectors. The crystal structure of Ra-
b6a(GTP) in complex with a 378-residue internal frag-
ment of the effector Rab6IP1 was solved at 3.2 A˚
resolution. This Rab6IP1 region encompasses an all
a-helical RUN domain followed in tandem by a
PLAT domain that adopts a b sandwich fold. The
structure reveals that the first and last a helices of
the RUN domain mediate binding to switch I, switch
II, and the interswitch region of Rab6. It represents
the largest Rab-effector complex determined to
date. Comparisons with the recent structure of
Rab6 in complex with an unrelated effector, human
golgin GCC185, reveals significant conformational
changes in the conserved hydrophobic triad of
Rab6. Flexibility in the switch and interswitch regions
of Rab6 mediates recognition of compositionally
distinct a-helical coiled coils, thereby contributing
to Rab6 promiscuity in effector recruitment.
INTRODUCTION
The architecture of eukaryotic cells consists of a complex assort-
ment of subcellular compartments and the underlying cytoskel-
etal network. The nucleus, endoplasmic reticulum (ER), Golgi
apparatus, mitochondria, and a variety of vesicular bodies
perform coordinated exchange of cargo throughout the life cycle
of cells. The p21 Ras superfamily of small GTPases are spatial/
temporal switches that choreograph diverse processes such
as organelle dynamics, cell proliferation, chemotaxis, synaptic
transmission, and cytokinesis (Goldfinger, 2008).
The complexity of eukaryotic intracellular trafficking is re-
flected in the evolutionary diversity of rab genes, which are
considered the premier organizers of membranes and vesicle
trafficking pathways (Zerial and McBride, 2001). Rab GTPases
comprise the largest member of the Ras superfamily with nearly
70 proteins, several of which are conserved from yeast to hu-
mans (Stenmark and Olkkonen, 2001). Following biosynthesis,Structure 17Rabs are guided to their cognate membranes via interactions
with Rab escort protein (REP), which is an essential accessory
protein for subsequent prenylation of C-terminal Cys residues
by geranylgeranyl transferase (GGTase) (Andres et al., 1993;
Farnsworth et al., 1991; Goody et al., 2005). Rabs oscillate
between inactive (GDP-bound) cytosolic, and active (GTP-
bound) membrane-associated states, and this cycle is regulated
by several accessory proteins. GDP dissociation inhibitors
(GDIs) trap Rabs in the inactive state and participate in the
membrane association/dissociation process (Wu et al., 1996),
GDP/GTP exchange factors (GEFs) activate Rabs by promoting
nucleotide exchange (Geyer and Wittinghofer, 1997), and
GTPase activating proteins (GAPs) accelerate hydrolysis of the
g-phosphate of bound GTP (Geyer and Wittinghofer, 1997).
Active Rabs interact with the Rab-binding domain (RBD) of
their cognate effectors to recruit them to specific subcellular
compartments. Each Rab interacts with a unique subset of
effector proteins, often unrelated in sequence and structure.
Effectors are typically multidomain proteins that, in addition to
the RBD, also contain additional domains that mediate biological
effects upon Rab recruitment. Thus, a snapshot of the cell would
reveal the dynamic association of innumerable Rab-effector
complexes regulating the exchange of cargo between subcel-
lular compartments. The Structural Genomics Consortium along
with independent labs has collectively determined the structures
of most Rabs in the human genome. All known Rabs except inac-
tive Rab27 (Chavas et al., 2007) share an identical a/bRas super-
family fold. However, only seven sets of Rab-effector crystal
structures are known: (i) Rab3-Rabphilin-3 (Ostermeier and
Brunger, 1999), which delivers secretory granules in several
cell types, although the biologically relevant complex is probably
Rab27-Rabphilin-3 (Fukuda, 2006); (ii) Rab5-rabaptin5 (Zhu
et al., 2004), involved in early endosome fusion; (iii) Rab7-RILP
(Rab7-interacting lysosomal protein) (Wu et al., 2005), which
regulates fusion between lysosomes and endosomes; (iv)
Rab4/Rab22 each with rabenosyn5 (Eathiraj et al., 2005),
involved in coordinating endosomal traffic through simultaneous
complex formation with Rab5; (v) Rab11-FIP2 (Rab11-family
interacting protein 2) from our group (Jagoe et al., 2006), and
Rab11-FIP3 from two other labs (Eathiraj et al., 2006; Shiba
et al., 2006), which regulate endocytic recycling pathways; and
(vi) Rab6 in complex with the RBD of GCC185, a golgin involved
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Structure of Rab6-R1P Complexstructure (Burguete et al., 2008; Derby et al., 2007). Finally, the
structures of Rab27B and Rab27A in complex with the RBDs
of two different effectors (Rab27B-slac2-a/melanophilin, 140-
residue RBD; Rab27A-Slp2a, 50-residue RBD) have also
recently been deposited in the Protein Data Bank (Chavas
et al., 2008). Without exception, all known Rab-effector
complexes are characterized by one or two a helices from the
RBD of the effector in intimate contact with the GTP-sensitive
switch I/II regions from the cognate Rab. Apart from Rabphilin-3
and melanophilin (120–140 residues), the short RBDs from
Rab-effector structures (40–60 residues) might appropriately
be termed a-helical ‘‘motifs’’ rather than domains. In addition,
a strictly conserved aromatic triad from Rabs (Phe in switch I,
Trp in the interswitch, and Tyr/Phe in switch II) contributes to
the binding interface with effectors. The side-chain conforma-
tions of the triad are variable, and this conformational heteroge-
neity is believed to contribute to Rab-effector specificity (Eathiraj
et al., 2005; Merithew et al., 2001).
Rab6 regulates transport pathways at the level of Golgi. Three
members of the Rab6 family have been identified to date: Rab6a,
Rab6a0 (which is a splicing variant of a duplicated exon, differing
from Rab6A by 3 residues), and Rab6b, which is preferentially ex-
pressed in a subset of neuronal cells (Darchen and Goud, 2000;
Opdam et al., 2000). Using the transport of Shiga toxin B-subunit
as a model system, it has been shown that Rab6 regulates endo-
some-to-Golgi and Golgi-to-ER retrograde transport pathways
(Del Nery et al., 2006; Mallard et al., 2002; White et al., 1999). A
role for Rab6 in the organization of exocytic vesicles that are
delivered from the Golgi apparatus to the cell membrane has
also been recently documented (Grigoriev et al., 2007). In addi-
tion, a small interfering RNA (siRNA) screen has linked Rab6 regu-
lation of Golgi retrograde pathways to human immunodeficiency
virus entry and productive infection (Brass et al., 2008). Several
unrelated Rab6 effectors have been identified using various
genetic and biochemical approaches, including subunits of the
dynein/dynactin complex, Rabkinesin-6/MKlP2, GAPCenA, Ra-
b6IP2/ELKS, TMF/ARA160, and mint3 (Cuif et al., 1999; Echard
et al., 1998; Fridmann-Sirkis et al., 2004; Miserey-Lenkei et al.,
2006; Short et al., 2002; Teber et al., 2005).
Figure 1. Domain Organization of RUN-
Domain-Containing Signaling Proteins
DENN indicates differentially expressed in
neoplastic versus normal cells; uDENN, upstream
DENN; dDENN , downstream DENN; CC1 and
CC2, coiled coil regions; FYVE, Fab1, YOTB,
Vac1, and EEA1 zinc finger domain; SH3, Src
homology 3 domain.
Rab6IP1, originally called orf37 (open
reading frame 37), was identified as
a Rab6(GTP)-specific binding protein
using a yeast two-hybrid screen of
a mouse brain cDNA library (Janoueix-
Lerosey et al., 1995). Two isoforms,
termed Rab6IP1A and Rab6IP1B and
differing by a stretch of 24 amino-acids
at their N termini, are ubiquitously ex-
pressed in mammals (Miserey-Lenkei
et al., 2007). The relative expression of each isoform depends
on tissues and cell types (Miserey-Lenkei et al., 2007). Endoge-
nous Rab6IP1 is a cytosolic protein recruited by active Rab6
(Rab6:GTP) onto Golgi membranes (Miserey-Lenkei et al.,
2007). Rab6IP1 also binds to Rab11 in a GTP-dependent
manner, suggesting that Rab6IP1 links the functions of Rab6
and Rab11 in transport events between Golgi and endosomes
(Miserey-Lenkei et al., 2007).
The primary sequence of Rab6IP1 reveals a modular organiza-
tion typical of many Rab effectors (Figure 1). Previous deletion
studies narrowed the Rab6-binding segment to 683–1061, which
spans the first RUN domain (RUN1) of Rab6IP1, followed by
a PLAT domain (Miserey-Lenkei et al., 2007). RUN domains are
widespread in cytosolic proteins and are presumed to have
diverse roles in cellular signaling (Callebaut et al., 2001; Mori
et al., 2007). The RUN acronym was coined after three members
of the family: the RPIP8 protein, an effector of Rap2 (Bourne
et al., 1991); UNC-14, a protein that plays a role in axonal elon-
gation and guidance in C. elegans (Ogura et al., 1997); and
NESCA (new molecule containing SH3 domain at the carboxy
terminus), an SH3 domain-containing protein cloned from
human placental cells. A common feature of some of these
proteins is their link to small GTPase functions (Rab6IP1, Rap2-
IPX, Rabip4). Recently, the isolated crystal structure of the RUN
domain of Rap2IPX revealed an 8-helix bundle with a novel
topology, but the complex with its signaling partner remains to
be determined (Kukimoto-Niino et al., 2006). The PLAT domain,
also referred to as LH2 (lipoxygenase homology domain 2) (Bate-
man and Sandford, 1999), was named after three members in
which this motif was discovered: polycystin-1, the product of
polycystic kidney disease 1 (PKD1) associated with renal cysts
and kidney disease (Sandford et al., 1997); lipoxygenases, multi-
subunit enzymes involved in the biosynthetic pathway of
hormones from lipid substrates (Gillmor et al., 1997); and
alpha-toxin, a pore-forming molecule expressed by pathogenic
bacteria. The function of this b sandwich domain remains ill-
defined, although it is generally observed in proteins that interact
with phospholipid bilayers and there is experimental support for
roles in protein-protein and protein-lipid interactions (Aleem22 Structure 17, 21–30, January 14, 2009 ª2009 Elsevier Ltd All rights reserved
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Structure of Rab6-R1P Complexet al., 2008; Bateman and Sandford, 1999; Hu and Barr, 2005;
Ponting et al., 1999).
In order to understand the structural basis for Rab-effector
specificity and function, we have determined the crystal struc-
ture of the 378-residue RUN1-PLAT fragment of Rab6IP1 in
complex with Rab6 by single-wavelength anomalous diffraction
(SAD) methods. The structure reveals that Rab6 binding is medi-
ated by noncontiguous a1 and a8 of the RUN1 domain. Compar-
ison with the structure of Rab6 in complex with the human golgin
protein GCC185 shows similarities in the nature of the Rab-
effector interface and topology of the two effector a helices.
However, the strictly conserved aromatic triad of Rab6 reveals
conformational flexibility in adapting to the hydrophobic inter-
face presented by two unrelated effectors, which has not been
described previously in Rab-effector complexes.
RESULTS
Identification of the Rab6-Binding Segment of Rab6IP1
Yeast two-hybrid analyses and GST-pull down experiments had
previously established that the minimal Rab6 binding segment of
mouse Rab6IP1 comprises residues 683–1061 (Figure 1), which
encompass a tandem RUN1-PLAT domain organization (Mi-
serey-Lenkei et al., 2007). This segment of RUN1-PLAT, which
will henceforth be referred to as ‘‘R1P’’, is indistinguishable
between the Rab6IP1A and Rab6IP1B isoforms. We subcloned
the R1P fragment into various Escherichia coli vectors, but all
attempts at soluble expression failed. Coexpression of R1P
with human Rab6a (residues 8–195, Q72L mutant) resulted in
a soluble complex that crystallized in a hexagonal space group
P6122, with one Rab6-R1P complex in the asymmetric unit.
Static light scattering indicated a 1:1 complex of Rab6 and
R1P in solution (see Figure S1 available online). Once the crystal
structure was solved, it was evident that Rab6-R1P interactions
are mediated solely by its RUN1 domain in the final refined
model. We designed various constructs to independently
express RUN1, either alone or together with Rab6. However,
all expression strategies to generate RUN1 alone or in complex
with Rab6 failed to produce soluble RUN1 protein in E. coli.
Furthermore, yeast two-hybrid analyses of RUN1 and Rab6
failed to show an interaction (Table S2). Possible explanations
for these observations will be discussed below.
Structure of R1P
The RUN1 domain is a 9-helix bundle that is dominated along
one side by the 33-residue N-terminal a helix (Figure 2). Most
of the a helices pack together with antiparallel or perpendicular
topology, organized roughly into a Greek key resembling the
death domain family. One notable exception is the pair of helices
a1/a8 that are parallel and which form the Rab6 binding inter-
face. In the complex Rab6-R1P, interactions with Rab6 are
mediated exclusively via RUN1. The structure of RUN1 is similar
to the recently determined crystal structure of the isolated RUN
domain from Rap2IPX (Kukimoto-Niino et al., 2006), with an root-
mean-square deviation (rmsd)of 1.83 A˚ over 162 Ca atoms (23%
sequence identities). The structure of Rap2IPX was determined
after optimization of soluble protein expression using NMR het-
eronuclear single-quantum coherence experiments of various
fragments of the RUN domain. These NMR studies suggestedStructure 17that the globular portion of the RUN domain extends further
toward the N terminus than predicted by the initial bioinformatics
studies of the RUN domain family (Callebaut et al., 2001). Subse-
quently, the crystal structure of Rap2IPX revealed that this region
adopts the N-terminal helix that is presumably essential for
correct folding of the RUN domain, and due to poor sequence
conservation, it was overlooked in multiple sequence align-
ments. Interestingly, the equivalent N-terminal helix of R1P is
one of the two helices that binds to Rab6.
The main differences in the two RUN domains are localized to
the a3-a4 loop and the C terminus (Figure 3). The long axis of a3
in R1P is rotated about 36 relative to a3 of Rap2IPX, despite
a conserved Trp hydrophobic anchor (Trp794 in RUN1) at the
base of the helices. A tight turn linking a3-a4 in Rap2IPX, aided
by Pro159 in the loop, may explain the closer packing of the
two helices in Rap2IPX. In contrast, there is a 32-residue inser-
tion in the a3-a4 loop of R1P, the majority of which is disordered
(residues 809-830 of RUN1). Following a8, the two RUN domains
share a common C-terminal helix (a9), but their backbones
follow very different paths relative to each other. The a9 of R1P
is sandwiched between the globular RUN1 domain and the
subsequent PLAT domain (Figure 3), whereas the C-terminal
helix of Rap2IPX extends away from the globular portion of the
Figure 2. Ribbon Model of the Rab6-Rab6IP1 Complex
Switch I is colored blue, and switch II is red. Interactions with Rab6 are
restricted to a1 and a8 of the RUN1 domain. The intervening helix a9 (residues
919–926) mediates intimate contacts with the all-helical RUN1 domain and
loops from the PLAT b sandwich., 21–30, January 14, 2009 ª2009 Elsevier Ltd All rights reserved 23
Structure
Structure of Rab6-R1P Complexmolecule. Intriguingly, in R1P there are extensive hydrophobic
interactions between the loops from PLAT and a9, a4, and a5
of the RUN1 domain. Furthermore, part of the loop preceding
a4 (residues 831–836) has been modeled on the surface of the
PLAT domain (Figure 3), guided by a continuous stretch of elec-
tron density and the presence of a SeMet (Met833) as an anchor
upon inspection of electron density maps. These interactions
lead to a tight association of RUN1 and PLAT domains, so that
the tandem RUN1-PLAT segment of Rab6IP1 can be considered
a rigid two-domain module. These structural properties might
explain the apparent instability of smaller R1P fragments, in
particular the inability to express a soluble complex of the
RUN1 domain with Rab6.
Rab6 Interface with RUN1 and Rab-Effector Specificity
A hydrophobic interface involving residues from switch I/II and
the interswitch of Rab6 (Ile46, Ile48, Phe50, Trp68, Phe75,
Leu78, and Tyr82) packs against the parallel a1/a8 helices of
RUN1 (Figures 4 and 5). Both RUN1 a helices supply charge
complementarity with Rab6, forming ion pairs Lys13-Asp901,
Arg74-Glu749, whereas Asp49 is in the neighborhood of both
Arg735 and Lys739. The key determinant in GTP specificity is
the ‘‘IGIDF’’ motif of switch I, whose conformation is influenced
by the presence of g-phosphate, and which resides in the a1/
a8 interface, contributing both hydrophobic interactions and
a salt bridge. The overall buried surface area in the complex is
1506 A˚2 . The nature of the binding interface can be described
as a central hydrophobic core, bordered by charge complemen-
tarity (Figure 6). In this respect, the complex resembles very much
the complexes Rab11-FIP2 and Rab11-FIP3 in the overall mode
of recognition. However, the Rab6-R1P complex is organized
Figure 3. Superposition of the RUN
Domains of Rab6IP1 and Rap2IPX
The PLAT domain of Rab6IP1 is colored blue (resi-
dues Ile928–Val1048) to distinguish it from the
RUN1 domain (Asn713–Thr927) of Rab6IP1.
Extensive polar and nonpolar interactions are
evident between the loops connecting the b sand-
wich of the PLAT domain with the short intervening
helix (a9) that packs against the globular RUN1
domain. This intervening a helix, which buffers
the interactions with PLAT, is not conserved in
the RUN domain of Rap2IPX (red).
(Right, bottom) Part of the loop connecting a3 and
a4 of RUN1 (residues 831–837) is modeled on the
surface of the b sheet of the PLAT domain, thereby
reinforcing the interactions between the two
domains. The electron density (2Fo-Fc) is con-
toured at 1s.
Figure 4. Electron Density (2Fo-Fc, 1.0s) at the Rab6-R1P Interface
Rab6 is gray (left), a1/a8 helices of R1P are green, and the blue Mg2+ ion, adja-
cent to GTP (magenta), is represented as a sphere.
such that two noncontiguous a helices
a1/a8 of Rab6IP1 form the Rab-binding
interface, unlike Rab11-FIP2, Rab6-
GCC185, and Rab5-rabaptin5 in which
parallel a helices are formed through
dimerization of the effectors. Rab7-RILP,
like the present structure, is a 1:1
complex, but the RBD is a contiguous
segment of polypeptide in which the two
a helices have antiparallel topology, and only one helix interacts
with Rab7.
The switch and interswitch residues of Rab6 that recognize
Rab6IP1 are highly conserved among human Rabs. However,
one of the key determinants of specificity is Lys13 of Rab6, which
resides on b1 and forms a salt bridge with Asp901. Lys13 is
a hydrophobic residue in other human Rabs (Figure 5), but apart
from this, all other residues that interact with R1P are either
identical or conservative changes in other Rab proteins. The
apparent dilemma in Rab-effector specificity is resolved by vari-
ability in the three-dimensional spatial position and conformation24 Structure 17, 21–30, January 14, 2009 ª2009 Elsevier Ltd All rights reserved
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Structure of Rab6-R1P Complexof conserved switch and interswitch residues, which cannot be
deduced from phylogenetic relationships in their DNA and
protein sequences (Collins, 2005). Conformational variability in
the switch and interswitch regions of active Rabs is now well
documented in numerous crystal structures, despite their high
sequence conservation (Eathiraj et al., 2005, 2006; Jagoe
et al., 2006; Shiba et al., 2006). Thus, the overall scaffold sup-
porting the switch regions influences the ‘‘exquisitely’’ specific
interactions with effectors.
Mutations in the RUN1 Domain Impair Recruitment
of Rab6IP1 to Golgi Membranes
When expressed in HeLa cells, green fluorescent protein (GFP)-
tagged wild-type Rab6IP1 is targeted to Golgi membranes
Figure 5. Sequence Alignments of RUN1,
PLAT, and Human Rabs
The secondary structures corresponding to the
Rab6-R1P structure are marked above the
sequences. The two a helices that interact with
Rab6 (A) are labeled RBD (Rab-binding domain)
for convenience. The arrows (B) mark the b strands
of the PLAT domain. The residues from Rab6 (C)
that interact with R1P are indicated with black
dots (d) above the single-letter codes. The smaller
black dots indicate every tenth residue in the
sequences (1, 11, 21, etc.). The variable tails of
Rabs have been excluded from the alignment.
(Miserey-Lenkei et al., 2007) (Figure 7,
upper panel). Depletion of Rab6 by siRNA
results in a cytosolic localization of GFP-
Rab6IP1, suggesting that Rab6 recruits
Rab6IP1 on Golgi membranes. In support
of the structural model of Rab6-R1P, we
have introduced a single site mutation
on a8 (K739E) in full-length Rab6IP1,
as well as a double mutation on a1
(Y908S+L911A). Tyr908 interacts with
the invariant Trp67 of the Rab6 aromatic
triad, and along with Leu911, forms part
of the hydrophobic interface. Lys739 of
Rab6IP1 forms a salt bridge with Asp49
from switch I. As shown in Figure 7
(middle and lower panels), the two
mutants failed to be efficiently targeted
to Golgi membranes and remained cyto-
solic, indicating that Lys739, Tyr908,
and Leu911 are crucial for Rab6-R1P
interaction in vivo. In addition, yeast
two-hybrid analyses revealed that the
mutant Rab6(I46E) failed to interact with
Rab6IP1 (Table S2). Ile46 from switch I is
located at the interface of helices a1/a8
of Rab6IP1 in the complex, thus forming
key hydrophobic contacts that would be
destabilized in the mutant protein. Alto-
gether, the above experiments indicate
that the interactions between Rab6 and
the RUN1 domain of Rab6IP1 are required for Rab6-dependent
recruitment of Rab6IP1 on Golgi membranes.
DISCUSSION
Comparisons of Rab6-Rab6IP1 with Rab6-GCC185
The structure of human Rab6a (Q72L, GTP-bound) was recently
determined in complex with the golgin GCC185. This complex
is organized as a heterotetrameric Rab6-(GCC185)2-Rab6
complex with the 37 residues of GCC185 forming the central
parallel coiled coil (Figure 8). Therefore, the two complexes allow
an unprecedented opportunity to compare the structural basis
for recruitment of two unrelated effectors. There are similarities
in the two complexes: both involve two parallel a helices inStructure 17, 21–30, January 14, 2009 ª2009 Elsevier Ltd All rights reserved 25
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switch regions of Rab6. Arg74 makes electrostatic contacts in
both complexes, although to different a helices upon structural
alignment, and there is a hydrophobic interface formed by both
a helices from the effector (Figure 6). Tyr908 of Rab6IP1 is
roughly the equivalent of Ile1588 in GCC185, mediating hydro-
phobic contacts with switch II. The buried surface is 1250 A˚2
for each side of the Rab6-GCC185 complex, compared with
1506 A˚2 for the single Rab6-R1P interface.
Despite a general resemblance in the mode of binding, the
Rab6-complementary patches of RUN1 and GCC185 bear no
compositional or structural resemblance to each other. In order
to recruit two unrelated effectors, there is a conformational rear-
rangement in the hydrophobic triad of Rab6 (Phe50, Trp67,
Tyr82; Figure 9 and Table S1). These dramatic changes take
place in the context of modest conformational changes in the
other interacting residues from Rab6. The rmsd for the backbone
of 158 aligned Rab6 residues by secondary structure matching
Figure 6. Electrostatic and Hydrophobic
Complementarity in Rab6-Effector Com-
plexes
Rab6A in the Rab6-R1P complex is on the left
(yellow ribbons/sticks), whereas Rab6A in the
Rab6-GCC185 complex is on the right side (green
ribbons/sticks). The Rabs are docked onto the
electrostatic surface of the effectors (red, negative
charge; blue, positive charge).
was 1.07 A˚. Phe50 in the Rab6-R1P
complex is packed between Gln905 and
Tyr908 from one helix (a8), whereas
Phe50 in the Rab6-GCC185 complex
packs against the other helix of GCC185
(Met1590). Trp67 forms a key hydro-
phobic interface with the equivalent a helix in both complexes,
forming interactions with Tyr908 of R1P (a8) and Thr1585/
Ile1588 in GCC185. Comparisons with uncomplexed Rab6(GTP)
reveal that the triad conformation resembles that found in the
Rab6-GCC185 complex. Binding of Rab6(GTP) to R1P would
entail large rotations about the c1 dihedral angle for Phe50 and
Trp67 (Table S1). Although there are also significant conforma-
tional changes in Tyr82 (switch II), analyses of this region are
complicated by the well-documented intrinsic flexibility of switch
II (Bergbrede et al., 2005). Indeed, there is a rigid-body movement
of the switch II helix in the aligned Rab6 molecules from the two
complexes, placing the Ca atoms of Tyr82 about 1.8 A˚ apart
from each other.
Previously, conformational heterogeneity in the triad has been
observed between different Rabs in their active state, presum-
ably as a consequence of the compositional and structural diver-
sity in the underlying hydrophobic core (Merithew et al., 2001).
Here we find conformational flexibility within the hydrophobic
Figure 7. Mutagenesis of Rab6IP1 and
Cellular Localization
Hela cells were transfected with GFP-Rab6IP1A
wild-type (WT), GFP-Rab6IP1A(K739E), or GFP-
Rab6Ip1A(Y908S+L911A) for 48 hr. Cells were
fixed and labeled with an antibody directed
against the Golgi marker.26 Structure 17, 21–30, January 14, 2009 ª2009 Elsevier Ltd All rights reserved
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Currently, the structural basis for the conformational rearrange-
ments is unknown. It is unclear whether effector binding shapes
the conformation of the triad, or whether the aromatic residues
are inherently flexible and a particular conformation is captured
by the distinctive interface of the effector. As an example,
Phe48 of Rab11 is observed in two distinct conformations, de-
pending on the presence of GTPgs or GppNHp at the nucleotide
binding site (Figure 9). Detailed thermodynamic and biophysical
studies may distinguish the underlying mechanisms involved in
effector recruitment. In concert with the apparent intrinsic flexi-
bility of switch II regions in many Rabs (Bergbrede et al., 2005;
Jagoe et al., 2006), these structural properties might explain the
promiscuity of Rabs in binding unrelated effector proteins.
Rab6-Rab6IP1-Rab11 Complex and the PLAT Domain
Beyond effector recruitment, an understanding of the biological
function of Rab-effector complexes requires the crystallization
Figure 8. Comparisons of the Structures of Rab6-R1P and Rab6-
GCC185
The R1P model has been stripped of the PLAT domain for clarity. A similar
orientation and color scheme is shown to emphasize the similarities and differ-
ences in the overall organization of the two complexes.Structure 1of more complete fragments of effector proteins. The Rab6-R1P
complex, the largest Rab-effector structure determined to date,
provides an opportunity to glean the possible contribution of the
PLAT domain to Rab6IP1 function. The various roles ascribed to
PLAT domains include binding to the b subunit of ATP synthase
in sensory cilia of C. elegans (Hu and Barr, 2005) and membrane
localization of lipoxygenases (Walther et al., 2002). The PLAT
domain of the Rab6-R1P complex reveals a possible lipid-binding
region (loops connecting b1-b2, b3-b4, and b5-b6; Figure S2) on
the distal end of the molecule opposite the RUN1 domain. Super-
position of the PLAT domains of several unrelated proteins
suggests a topology for the b sandwich that would be consistent
with a lipid-facing orientation. However, the role of the PLAT
domain requires further clarification with lipid-binding studies,
mutagenesis experiments, and vesicle trafficking assays. The
tandem RUN1-PLAT domains are a rigid unit, as evidenced by
extensive interactions between the proximal loops of the b sand-
wich and a9 of RUN1. In contrast, the low-resolution model of 12-
lipoxygenase shows considerable flexibility in the linker between
the PLAT domain and the catalytic domains (Aleem et al., 2008).
A GTP-dependent interaction between Rab11 and Rab6IP1
has been demonstrated using several approaches (Miserey-Len-
kei et al., 2007). The overexpression of Rab6IP1 leads to a redis-
tribution of peripheral Rab11 positive recycling endosomes
toward the Golgi complex. This suggests the existence of ternary
complexes between Rab6, Rab11, and Rab6IP1 (Miserey-Len-
kei et al., 2007). A tentative hypothesis is that the PLAT domain
of R1P might be interacting with membranes of recycling endo-
somes and participating together with Rab11 in the tethering of
these membranes with Golgi membranes. Crystallization of the
complete Rab6IP1 molecule along with Rab6/Rab11 in a ternary
complex would provide further insight into the functional trans-
port links between Golgi and endosomes.
EXPERIMENTAL PROCEDURES
Expression and Purification of Rab6-R1P
The RUN1-PLAT region (683–1061, henceforth referred to as R1P) of mouse
Rab6IP1 was cloned into the Nde1/BamH1 site of the pET15 vector (ampicillin
resistance). The recombinant protein lacked an affinity tag when expressed in
E. coli. Human Rab6a (residues 8–195, Q72L) was cloned into the Nde1/Xho1
restriction sites of pET28 (kanamycin resistance), thus recombinant Rab6 con-
tained an N-terminal His-tag (thrombin cleavage site). The two constructs
were cotransformed into E. coli BL21(DE3) cells, and all subsequent small and
large-scale cultures (including minimal media) were supplemented with 100
mg/ml ampicillin and 30 mg/ml kanamycin. Large-scale cultures were initially
grown at 310 K in 2xYT media until the OD600 was 0.6. The culture temperature
was switched to 298 K and protein expression was induced by the addition of
IPTG (0.2 mM) for approximately 6 hr. The cells were harvested by centrifugation
at 4,000 rpm for 10 min and resuspended in 10 mM Tris-Cl (pH 8.0), 300 mM
NaCl, 5 mM MgCl2, 10 mM imidazole, and 10mMb-mercaptoethanol (extraction
buffer). The cells were sonicated and the lysates centrifuged at 20,0003g for 30
min to eliminate insoluble protein and cellular debris. The Rab6-R1P complex
was loaded onto Ni2+-agarose (Chromatrin) via the N-terminal His-tag of
Rab6. Following extensive washing with extraction buffer, the complex was
eluted with a step gradient of 200 mM imidazole. Cleavage of the His-tag was
performed in the presence of 10 units/mL of thrombin (GE Healthcare) overnight
in dialysis sacs (10 mM Tris-Cl, 150 mM NaCl, 5 mM MgCl2, 10 mM imidazole,
and 10 mM b-mercaptoethanol [pH 8]). A second Ni2+-agarose chromatography
step was performed to eliminate uncleaved Rab6. Fractions containing the
thrombin-cleaved complex were pooled, concentrated, and loaded onto
a Superdex-200 size exclusion column (mounted on AKTAbasic FPLC, GE7, 21–30, January 14, 2009 ª2009 Elsevier Ltd All rights reserved 27
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Structure of Rab6-R1P ComplexHealthcare), equilibrated with 10 mM Tris-Cl, 100 mM NaCl, 5 mM MgCl2, and
1 mM DTT (pH 7.5). The eluted complex was concentrated to 7–10 mg/ml before
crystallization.
For the production of selenomethionine derivatized protein, recombinant
expression was performed in the methionine auxotrophic E. coli strain
B834(DE3). A 5 ml overnight culture in LB medium was used to inoculate
a 0.5 l culture of M9 media, supplemented with vitamins, trace elements, and
40 mg/l of all amino acids except Met, according to the method of Van Duyne
(Van Duyne et al., 1993). The culture was grown at 310 K to an OD600 of 0.4. At
this point, 100 mg/l SeMet was added and culture was switched to 298 K for an
additional 30 min. Protein expression was induced with 0.2 mM IPTG and
growth continued at 298 K for 8 hr. SeMet substituted protein was purified as
before except for an increase in the concentration of b-mercaptoethanol
(20 mM) and DTT (2 mM) to protect the SeMet residues from oxidation.
Crystallization, Data Collection, and Structure Determination
Crystals were grown by hanging drop vapor diffusion at 18C. One microliter
7–10 mg/ml protein was mixed with one microliter mother liquor, consisting
of 100 mM HEPES (pH 7.0), 2%–4% PEG 4000, and 3% 2,4-methypentanediol
(MPD) on a siliconized coverslip. Hexagonal-shaped crystals grew to full size
(0.4 3 0.15 3 0.15 mm) after 2 weeks. Crystals were cryoprotected in
100 mM HEPES (pH 7.0), 2%–4% PEG 4000, 3% MPD, and 25% glycerol,
and then flash-frozen in liquid nitrogen.
The Rab6-R1P complex crystallized in space group P6122 with one complex
in the asymmetric unit. SAD data were collected at the sulfur peak wavelength
(0.978 A˚, 100 K) on beamline BM14 (ESRF), whereas high-resolution native
data for refinement were collected with a single native crystal on ID14-1
(ESRF). Data were processed using HKL2000, and intensities were reduced
and scaled using SCALEPACK (Otwinowski and Minor, 1997). The initial
phases and electron density map was obtained by SAD phasing using SOLVE
(Terwilliger and Berendzen, 1999). Subsequent density modification involved
solvent flattening (Wang, 1985) and histogram matching (Nieh and Zhang,
1999) as implemented in the Crystallography and NMR System (Brunger
et al., 1998). Exploiting the positions of selenomethionine as anchors, the initial
electron density maps allowed unambiguous chain tracing for most of the
protein backbone, side chain, and GTP. Progress was monitored with the
Figure 9. Hydrophobic Triads of Rabs
Mediate Binding to Cognate Effectors
Yellow coloring corresponds to active Rab (GTP or
analog) in the free state, whereas blue or red
coloring indicates the conformation of the triad in
the effector-bound state. The Rab6-R1P complex
(*) is the exception to the general observation that
the hydrophobic triads in the active (GTP) forms of
Rabs do not undergo significant conformational
changes upon binding to their cognate effectors.
One other exception is Rab11, which exists in
two alternate conformations at Phe48, depending
on the presence of GppNHp or GTPgS (Protein
Data Bank [PDB] codes 1yzk and 1oiw, respec-
tively). Details of the side-chain conformational
angles and the PDB codes of aligned structures
are listed in Table S1.
free R value using a 10% randomly selected test
set. Initial refinement consisted of torsion angle
dynamics simulated annealing (Rice and Bru¨nger,
1994) using the MLHL target function with the
experimental phases as a prior phase distribution
(Pannu et al., 1998), followed by model rebuilding
using the graphic program COOT (Emsley and
Cowtan, 2004). Later refinement consisted of
iterative rounds of model building and selection
of chemically reasonable water molecules in
phased-combined sA-weighted 2Fo-Fc maps,
conjugate gradient minimization, and individual (isotropic) restrained atomic
B-factor refinement with B-factor sharpening implemented in CNS version
1.2 (Brunger, 2007) using data between 50-3.2 A˚ resolution. Data and refine-
ment statistics are shown in Table 1.
In the final Rab6-R1P model, Rab6a is ordered between Asp12-Met177. The
R1P fragment (683–1066) is well defined for residues Asn713-Ala754, Asn759-
Leu808, and Ala831-Glu1047. A large disordered loop connecting a2-a3 of
RUN1 (residues Thr809-Ser830) is situated on the opposite side of RUN1 rela-
tive to the Rab6-binding face. Therefore, flexibility in this region does not
complicate subsequent discussions of Ra6-R1P recognition.
Yeast Two-Hybrid Assays
Yeast two-hybrid tests were performed as previously described (Janoueix-
Lerosey et al., 1995) using pLexA-Rab6a wt, pLexA-Rab6a T27N, pLexA-
Rab6a I46E, and pLexA-Rab6a Q72L as baits. Rab6IP1 constructs (R1P,
RUN1, RUN2; preys) were cloned into a pGAD vector.
In Vivo Analysis
Mutations K739E and Y908S+L911A were introduced into the pEGFPRa-
b6IP1A plasmid using site-directed mutagenesis (QuickChange, Stratagene).
The following oligonucleotides were used: Y908S+L911A mutant, sense oligo-
nucleotide 50-GAGCA-GTTCCTCTCTCACCTGGCCTCCTTCAACGCAGTG-30;
antisense oligonucleotide 50-CACTGCGTTGAAGGAGGCCAGGTGAGAGAGG
AACTGCTC-30; K739E mutant, sense oligonucleotide 50-GAATGTCGAAACAA
GACCGAGAGGATGCTGGTAGAG-30, antisense oligonucleotide CTCTACCA
GCATCCTCTCGGTCTTGTTTC-GACATTC-30. Cells were transfected for 48 hr
and processed for immunofluorescence analysis as previously described
(Miserey-Lenkei et al., 2007).
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Table 1. Data Collection and Refinement Statistics
Selenomethionine Native
Data Collection
Space group P6122 P6122
Cell dimensions 100.2, 299.3 99.9, 299.0
Wavelength (A
´
, Se peak) 0.978 0.934
Resolution (A
´
) 50-3.4 50-3.0
Completeness (%) 99.6 (100) 99.1 (98.6)
Rmerge (%) 12.4 (72.0) 6.0 (80.0)
I/s(I) all data — 13.3
I/s(I) > 3 (% of data) 88 85.8
Redundancy 22.9 (24.0) 9.2 (9.4)
Refinement
Resolution 50-3.2
Number of reflections 15,437
Models Rab6A (residues
12–177) R1P (713–754;
759–808; 831–1047)
Rwork/Rfree (%) 24.8/30.1
High-resolution shell (31.6/35.6)
Number of nonhydrogen
atoms
3,902
Protein 3,809
GTP, ions 34
Water 38
Average B-factor 101.6 A˚2
Wilson plot 101.2 A˚2
Rms deviations
Bond lengths (A
´
) 0.008
Bond angles () 1.20
Coordinate error (ESU, A˚) 0.40
Residues in Ramachandran
Most favored region 87.4%
Additionally allowed 12.1%
Generously allowed 0.5%
Disallowed 0%
Values in parentheses correspond to the statistics for the highest
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